Brief: Themis Medicare - Got DCGI Approval For Immunomodulatory Antiviral COVID-19 Drug Viralex

Themis Medicare

03/03/2022 13:55

March 3 (Reuters) - Themis Medicare Ltd  THEM.NS :
    * THEMIS MEDICARE LTD - RECEIVED APPROVAL FOR ITS
IMMUNOMODULATORY
ANTIVIRAL DRUG VIRALEX
    * THEMIS MEDICARE LTD - GOT APPROVAL FROM DRUG CONTROLLER
GENERAL
OF INDIA (DCGI)
    * THEMIS MEDICARE LTD - PERMISSION TO MANUFACTURE AND MARKET
THIS
NEW DRUG FOR RESTRICTED EMERGENCY USE FOR COVID-19 TREATMENT

Source text for Eikon:  ID:nBSEbnrJt9 
Further company coverage:  THEM.NS 

 ((Reuters.Briefs@thomsonreuters.com;))